Saturday, July 11, 2026

pharma · Hypertension · Breast Neoplasms

Pfizer

Pfizer is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Hypertension, Breast Neoplasms, Complicated Intra-abdominal Infection, Non-Small Cell Lung Cancer, Arthritis, Rheumatoid

New York 10017, US HQ
103,316 Employees
EMA registrant Type
Company details
Clinical program

PF-05280014

Phase 3 · mab · Metastatic Breast Cancer

PF-05280014 for Metastatic Breast Cancer is a Phase 3 program (mab) at Pfizer with 1 ClinicalTrials.gov record(s).

← All Pfizer projects Phase 3 mab completed

Internal code B3271002

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pfizer
Phase
Phase 3
Modality
mab
Indication
Metastatic Breast Cancer
Status
completed
Trials
1

Clinical trials